search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


An alternative approach for treatment of infantile esotropia with botulinum toxin A.


- candidate number14759
- NTR NumberNTR3959
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR18-apr-2013
- Secondary IDsNL42631.078.12 MEC-2012-564 / OZR-2012-07
- Public TitleAn alternative approach for treatment of infantile esotropia with botulinum toxin A.
- Scientific TitleAn alternative approach for treatment of infantile esotropia with botulinum toxin A.
- ACRONYM
- hypothesisThe proportion of successful alignment after treatment of infantile esotropia with Botox is not inferior to conventional strabism surgery.
- Healt Condition(s) or Problem(s) studiedInfantile esotropia
- Inclusion criteria1. No known/established neurological disease;
2. History of orthotropia;
3. No vertical deviation (no upshoots);
4. Non-accommodative (less than 3D spherical equivalent hyperopia);
5. Up to 40 ∆ esotropia;
6. Free alternators;
7. Difference in refraction between both eyes ≤ 1.5 D.
- Exclusion criteria1. Previous strabismus surgery;
2. Retinal disease;
3. Any medical condition that would preclude general anesthesia with sevoflurane;
4. Hypersensitivity to any Botox ingredient;
5. Muscular disease such as myasthenia gravis or Eaton-Lambert syndrome.
- mec approval receivedyes
- multicenter trialno
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeintervention
- planned startdate 1-jun-2013
- planned closingdate31-mrt-2016
- Target number of participants40
- InterventionsBilateral injection of Botox in the medial rectus muscle.
- Primary outcomeProportion of successful motor alignment at six months. This will be measured with a synoptophore. Successful alignment is defined as ≤ 10 prism diopters of residual esotropia at 6 months.
- Secondary outcome1. Degree of esotropia (prism diopters);
2. Time of onset esotropia;
3. Measurement of binocularity: alignment & fusion;
4. Percentages and duration of ptosis and exotropia (temporary side effects of botulinum injection);
5. Percentages of reinjection and additional alignment surgery;
6. BCVA at each visit and amblyopia;
7. Occurrence of vertical disturbances of ocular motility;
8. Adverse events.
- TimepointsPreoperatively, postoperatively at 2 and 10 weeks, at 6 months and at 1 and 2 years.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIES Rene Wubbels
- CONTACT for SCIENTIFIC QUERIES Rene Wubbels
- Sponsor/Initiator The Rotterdam Eye Hospital
- Funding
(Source(s) of Monetary or Material Support)
Stichting Wetenschappelijk Onderzoek Oogziekenhuis (SWOO)
- PublicationsN/A
- Brief summaryRationale:
In comparison to standard strabism surgery in patients with infantile esotropia, bilateral injection of Botox in the medial rectus muscle is conjectured to be equivalent with respect to motor alignment, while burden and risk are (because less invasive) expected to be less.

Objective:
To determine the proportion of successful alignment after treatment of infantile esotropia with Botox.

Study design:
Prospective case series.

Study population:
Infantile esotropia < 6 years of age.

Intervention:
Bilateral injection of Botox in the medial rectus muscle.

Main study parameters/endpoints:
Proportion of successful motor alignment at six months.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:
As an alternative to conventional strabism surgery, treatment with Botox may be equally effective while both burden and risk are anticipated to be reduced.
- Main changes (audit trail)
- RECORD18-apr-2013 - 14-mei-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl